While some people might lose weight over time, the fact that the FDA hasnt approved compounded semaglutide raises concerns about its quality and safety, including risks like contamination or incorrect dosages
As an important part of that effort we voluntarily provide such material on our website
Retatrutide: no, investigational as of May 2026
The intent of this change is not to compromise the integrity or safety of any sport where alcohol use is a concern, but rather to endorse a different means of enforcing bans on alcohol use in these sports
Retatrutide is an investigational once-weekly injectable triple agonist that simultaneously activates GLP-1, GIP, and glucagon receptors, targeting appetite, glucose metabolism, and energy expenditure through a single agent
Should you take electrolytes